List of insiders holdings for Zenas BioPharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 2024-09-23 20:56:26 | 4,911,539 0 | 4,911,539 | Form 13D |
Enavate Sciences GP LLC Zebra Aggregator LP 10% Owner | 2024-09-23 16:16:03 | 3,761,359 0 | 3,761,359 | Form 13D |
Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 2024-09-17 20:56:05 | 0 1,929,806 | 1,929,806 | Form 4/A |
MOULDER LEON O JR Chief Executive Officer | 2024-11-20 17:20:29 | 171,155 1,672,039 | 1,843,194 | Form 4 |
Nunn Jason Raleigh Director | 2024-09-16 20:54:53 | 37,000 1,110,237 | 1,147,237 | Form 4 |
ENRIGHT PATRICK G Director | 2024-09-16 20:57:32 | 37,000 774,530 | 811,530 | Form 4 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2024-09-18 17:16:21 | 801,624 0 | 801,624 | Form 4 |
Oliveira Orlando Chief Commercial Officer | 2024-09-16 20:52:04 | 410,000 0 | 410,000 | Form 4 |
Farmer Joseph L See Remarks | 2024-09-16 20:50:11 | 206,000 0 | 206,000 | Form 4 |
Fox Jennifer A. See Remarks | 2024-09-16 20:48:37 | 155,000 0 | 155,000 | Form 4 |
Lu Hongbo Director | 2024-09-17 19:52:28 | 0 58,823 | 58,823 | Form 4 |
Boylan James P Director | 2024-09-16 20:55:32 | 37,000 0 | 37,000 | Form 4 |
Xiao Ting Director | 2024-09-16 21:03:54 | 37,000 0 | 37,000 | Form 4 |
Allen Patricia L Director | 2024-09-16 21:00:39 | 18,500 0 | 18,500 | Form 4 |
ORLOFF JOHN J Director | 2024-09-16 21:05:31 | 18,500 0 | 18,500 | Form 4 |